Navigation Links
Cost of Diabetes Care in U.S. Keeps Climbing
Date:3/6/2013

WEDNESDAY, March 6 (HealthDay News) -- The total cost of diabetes in the United States jumped from $174 billion in 2007 to $245 billion in 2012, a new report shows.

Last year's total cost included $176 billion in direct medical costs -- such as hospital and emergency care, medications and office visits -- and $69 billion in indirect costs, including work absenteeism, reduced productivity, unemployment caused by diabetes-related disability and lost productivity due to early death. The 2012 cost represents a 41 percent increase from 2007.

"As the number of people with diabetes grows, so does the economic burden it places upon [the United States]," Dr. Robert Ratner, chief scientific and medical officer at the American Diabetes Association, said in a news release from the association, which commissioned the study.

"When it comes to the rising cost of diabetes, one of the key factors explaining the increase is that there are many more people that are now being treated for diabetes in the U.S.," Ratner explained.

"It is important to note that while treating diabetes is expensive, it is the fact that the prevalence of the disease is increasing dramatically," Ratner added. "Recent estimates project that as many as one in three American adults will have diabetes in 2050. These numbers are alarming, and further highlight the need for our nation to address this epidemic."

Nearly 26 million adults and children in the United States have diabetes and another 79 million have prediabetes, which places them at increased risk for developing the disease.

"The cost of diabetes is rising at a rate higher than overall medical costs, with more than one in 10 health care dollars in the country being spent directly on diabetes and its complications, and more than one in five health care dollars in the U.S. going to the care of people with diagnosed diabetes," Ratner noted.

The study also found that medical costs for people with diabetes are 2.3 times higher than for those without diabetes, and that the primary cause of increased costs is the increasing number of people with diabetes.

Despite the introduction of new medications for the disease, diabetes drugs and supplies accounted for only 12 percent of the medical costs in both 2007 and 2012.

Among the other key findings:

  • Most (62 percent) of the cost for diabetes care in the United States is provided by government insurance (including Medicare, Medicaid and the military). The rest is paid for by private insurance (34 percent) or by the uninsured (3 percent).
  • Total per-person health costs are higher among women than men ($8,331 versus $7,458), and lower among Hispanics ($5,930) than among whites ($8,101) and blacks ($9,540).
  • The per-person cost of medical care attributed to diabetes was $6,649 in 2007 and $7,900 in 2012, a 19 percent increase. Overall, medical care costs in the United States rose by a comparable amount during the same time period, which indicates that the increasing cost of diabetes care is being driven by the increasing number of people with diabetes.
  • Among states, California has the largest population with diabetes and thus the highest costs, at $27.6 billion. Florida's total population is fourth among states behind California, Texas and New York, but it is second in diabetes-related costs at $18.9 billion.

The findings were released at a news conference March 6 and will appear in the April issue of the journal Diabetes Care.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases offers a diabetes prevention series.

-- Robert Preidt

SOURCE: American Diabetes Association, news release, March 6, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. How a cancer drug leads to diabetes
2. Heart failure patients with diabetes may benefit from higher glucose levels
3. Disrupted Sleep May Raise Risk for Obesity, Diabetes: Study
4. Mouse Study Hints at New Path for Diabetes Treatment
5. Common Plastics Chemical Might Boost Diabetes Risk
6. Weight-Loss Surgery Beat Drugs for Cutting Diabetes in Very Obese
7. Naturopathic care can improve blood sugar, mood in diabetes
8. Cellular pathway linked to diabetes, heart disease
9. Diabetes Groups Issue New Guidelines on Blood Sugar
10. Value of Metformin, Insulin Combo for Type 2 Diabetes Questioned
11. Xenotransplantation as a therapy for type 1 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cost of Diabetes Care in U.S. Keeps Climbing
(Date:6/24/2017)... ... June 24, 2017 , ... ... at the Sheraton Erie Bayfront and Erie Convention Center on June 8-10. ... exhibits, a student quiz bowl, award and scholarship presentations, and professional networking. ...
(Date:6/23/2017)... ... 23, 2017 , ... The Rhode Island Quality Institute (RIQI) ... and Dashboards, an innovative new service enabling healthcare providers to proactively coordinate care ... and Dashboards provide near real-time data about patients admitted to and/or discharged from ...
(Date:6/23/2017)... (PRWEB) , ... June 24, 2017 , ... Studies show ... significantly reduce the risk of visual loss in these patients. , But how often ... diet, or smoking cessation to patients at risk of or with early symptoms of ...
(Date:6/23/2017)... ... ... Everybody has their own personal preference when it comes to pornography. Some ... don't like it at all. FindaTopDoc took a look at what makes people attracted ... readers a taste of their deepest, darkest fantasies and has the ability to help ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... Cancer Conference from Sept. 18 to 20. , The two-day conference is focused ... with the goal of improving patients’ lives and eliminating racial breast cancer-related disparities. ...
Breaking Medicine News(10 mins):
(Date:6/13/2017)... June 13, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that the U.S. Food and Drug Administration (FDA) has ... 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning Letter related ... facility is a measure of the progress we have made ...
(Date:6/11/2017)... and Company (NYSE: LLY ) announced today ... an investigational treatment for the prevention of episodic and ... endpoints for galcanezumab compared to placebo at both studied ... REGAIN) will be presented today at the American Headache ... . "The detailed Phase 3 ...
(Date:6/9/2017)... PALO ALTO, Calif. , June 9, 2017 /PRNewswire/ ... medical device company focused on the design, manufacture, sale ... updated the market on the progress of its commercial ... AeroForm is now available in more than one hundred ... country. AeroForm offers a needle-free alternative ...
Breaking Medicine Technology: